Multidisciplinary Indian Consensus for Rationalizing the Use of Acid Suppressants in Children and Adults: Key Takeaways from CONFOR CONSENSUS MD Brand Connect17 July 2024 9:45 AM ISTA Multidisciplinary Consensus for Rationalizing the Use of Acid Suppressants in Children and Adults: CONFOR CONSENSUS has been recently published in...
2024 CONFOR Consensus: Rationalizing Use of Acid Suppressants in Children and Adults Dr. Kamal Kant Kohli10 July 2024 12:57 PM ISTConcern about the inappropriate use of proton pump inhibitors (PPIs) has been rising, with studies showing a lack of ongoing indication for PPI...
Indian Pharma Market registers 8 percent surge to Rs 17,937 Crore in January 2024: IQVIA Farhat Nasim19 Feb 2024 7:19 PM ISTNew Delhi: In an impressive kickoff to 2024, the Indian pharmaceutical market surged by 8%, reaching a substantial Rs 17,937 crore in January, as per...
Bedtime Ranitidine for Nighttime Acid Reflux: Choose your Option Wisely! Dr. Kamal Kant Kohli15 Feb 2024 11:45 AM ISTNighttime acid reflux commonly referred to as nocturnal acid breakthrough (NAB) is defined as a persistent decrease in intragastric pH below 4 for...
Considering Ranitidine in Episodic Heartburn Relief-A Practice Perspective Dr. Kamal Kant Kohli18 Jan 2024 11:14 AM ISTHeartburn is a cardinal symptom of gastroesophageal reflux disease (GERD). (1) It is defined as a sensation of burning discomfort in the chest, upper...
Safety of Ranitidine: A Fresh Look at an Old Gem Dr. Kamal Kant Kohli23 Nov 2023 11:09 AM ISTThe introduction of histamine type 2 receptor antagonists (H2RAs) has revolutionised the management of acid-related disorders. Ranitidine has been...
Ranitidine Use is Not Associated with an Increased Risk of Cancer, Finds Latest Multinational Study Involving Over 1.1 Million Patients Dr. Kamal Kant Kohli10 Oct 2023 11:30 AM ISTA recent multinational, multicentric cohort study published in JAMA Network Open has found no significant association between the use of the drug...
Adverse Effects of Proton Pump Inhibitor Use in Patients with Cardiovascular Disease: Pharmacovigilance Attention Needed!! Dr. Kamal Kant Kohli8 Sept 2023 11:30 AM ISTSince the introduction of proton pump inhibitors (PPIs), they have steadily become the mainstay in treating acid-related disorders. The adoption of...
PROGRADE Study Results: Ranitidine HCl Safe & Efficacious among Indian Patients with GERD MD Brand Connect8 Aug 2023 1:02 PM ISTPROGRADE trial confirms the safety and efficacy of ranitidine among Indian GERD patients PROGRADE Trial, a recent multicentric, multi-specialty...
Ranitidine Reaffirms Clinical Utility in Indian GERD Patients-Results of Latest PROGRADE Trial Dr. Kamal Kant Kohli3 Aug 2023 11:30 AM ISTRanitidine hydrochloride is safe and clinically effective among Indian patients suffering from Gastroesophageal Reflux Disease (GERD) with an...
Prophylactic Use Of Ranitidine in Pediatric Settings: Experts Opine Dr. Kamal Kant Kohli18 April 2023 10:54 AM ISTAcid suppression treatment has revolutionized the management of acid-related disorders since the introduction of H2-receptor antagonists (H2RAs) and...
Indian Experts Opinion on Proton Pump Inhibitors in Pediatrics: Too much of a good thing! Dr. Kamal Kant Kohli9 Feb 2023 12:57 PM ISTProton Pump Inhibitors (PPIs) have been widely used to treat acid peptic diseases for around three decades but have been under the scanner with...
